Mallinckrodt Plc is a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes branded medicines. The Specialty Generics segment relates to specialty generic drugs, active pharmaceutical ingredients, as well as external manufacturing. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Staines-Upon-Thames, the United Kingdom.
![Mallinckrodt logo](/files/LOGO/1766927-MNK.png)
Company profile
Website
CEO
Mark C. Trudeau
Employees
Location
Fiscal year end
Industry (SIC)
SEC CIK
IRS number
301163574
Latest ownership filings
No filings
Institutional ownership, Q1 2024
13F holders | Current |
---|---|
Total holders | 3 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 457.00 k |
Total shares | 3.69 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Buxton Helmsley | 3.43 mm | $457.00 k |
D. E. Shaw & Co | 253.23 k | $0.00 |
Huntington National Bank | 1.00 | $0.00 |